Cargando…
A prospective, randomized, double-blind, and multicenter trial of prophylactic effects of ramosetronon postoperative nausea and vomiting (PONV) after craniotomy: comparison with ondansetron
BACKGROUND: Craniotomy patients have a high incidence of postoperative nausea and vomiting (PONV). This prospective, randomized, double-blind, multi-center study was performed to evaluate the efficacy of prophylactic ramosetron in preventing PONV compared with ondansetron after elective craniotomy i...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124476/ https://www.ncbi.nlm.nih.gov/pubmed/25104916 http://dx.doi.org/10.1186/1471-2253-14-63 |
_version_ | 1782329624025366528 |
---|---|
author | Ryu, Jung-Hee Lee, Ji-Eun Lim, Young-Jin Hong, Deok-Man Park, Hee-Pyoung Han, Jong-In Baik, Hee-Jung Kim, Hyun-Zu Min, Kyeong-Tae Do, Sang-Hwan |
author_facet | Ryu, Jung-Hee Lee, Ji-Eun Lim, Young-Jin Hong, Deok-Man Park, Hee-Pyoung Han, Jong-In Baik, Hee-Jung Kim, Hyun-Zu Min, Kyeong-Tae Do, Sang-Hwan |
author_sort | Ryu, Jung-Hee |
collection | PubMed |
description | BACKGROUND: Craniotomy patients have a high incidence of postoperative nausea and vomiting (PONV). This prospective, randomized, double-blind, multi-center study was performed to evaluate the efficacy of prophylactic ramosetron in preventing PONV compared with ondansetron after elective craniotomy in adult patients. METHODS: A total of 160 American Society of Anesthesiologists physical status I–II patients aged 19–65 years who were scheduled to undergo elective craniotomy for various intracranial lesions were enrolled in this study. All patients received total intravenous anesthesia (TIVA) with propofol and remifentanil. Patients were randomly allocated into three groups to receive ondansetron (4 mg; group A, n = 55), ondansetron (8 mg; group B, n = 54), or ramosetron (0.3 mg; group C, n = 51) intravenously at the time of dural closure. The incidence of PONV, the need for rescue antiemetics, pain score, patient-controlled analgesia (PCA) consumption, and adverse events were recorded 48 h postoperatively. RESULTS: Among the initial 160 patients, 127 completed the study and were included in the final analysis. The incidences of PONV were lower (nausea, 14% vs. 59% and 41%, respectively; P < 0.001; vomiting, P = 0.048) and the incidence of complete response was higher (83% vs. 37% and 59%, respectively; P < 0.001) in group C than in groups A and B at 48 h postoperatively. There were no significant differences in the incidence of PONV or need for rescue antiemetics 0–2 h postoperatively, but significant differences were observed in the incidence of PONV and complete response among the three groups 2–48 h postoperatively. No statistically significant intergroup differences were observed in postoperative pain, PCA consumption, or adverse events. CONCLUSION: Intravenous administration of ramosetron at 0.3 mg reduced the incidence of PONV and rescue antiemetic requirement in craniotomy patients. Ramosetron at 0.3 mg was more effective than ondansetron at 4 or 8 mg for preventing PONV in adult craniotomy patients. TRIAL REGISTRATION: Clinical Research Information Service (CRiS) Identifier: KCT0000320. Registered 9 January 2012. |
format | Online Article Text |
id | pubmed-4124476 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-41244762014-08-08 A prospective, randomized, double-blind, and multicenter trial of prophylactic effects of ramosetronon postoperative nausea and vomiting (PONV) after craniotomy: comparison with ondansetron Ryu, Jung-Hee Lee, Ji-Eun Lim, Young-Jin Hong, Deok-Man Park, Hee-Pyoung Han, Jong-In Baik, Hee-Jung Kim, Hyun-Zu Min, Kyeong-Tae Do, Sang-Hwan BMC Anesthesiol Research Article BACKGROUND: Craniotomy patients have a high incidence of postoperative nausea and vomiting (PONV). This prospective, randomized, double-blind, multi-center study was performed to evaluate the efficacy of prophylactic ramosetron in preventing PONV compared with ondansetron after elective craniotomy in adult patients. METHODS: A total of 160 American Society of Anesthesiologists physical status I–II patients aged 19–65 years who were scheduled to undergo elective craniotomy for various intracranial lesions were enrolled in this study. All patients received total intravenous anesthesia (TIVA) with propofol and remifentanil. Patients were randomly allocated into three groups to receive ondansetron (4 mg; group A, n = 55), ondansetron (8 mg; group B, n = 54), or ramosetron (0.3 mg; group C, n = 51) intravenously at the time of dural closure. The incidence of PONV, the need for rescue antiemetics, pain score, patient-controlled analgesia (PCA) consumption, and adverse events were recorded 48 h postoperatively. RESULTS: Among the initial 160 patients, 127 completed the study and were included in the final analysis. The incidences of PONV were lower (nausea, 14% vs. 59% and 41%, respectively; P < 0.001; vomiting, P = 0.048) and the incidence of complete response was higher (83% vs. 37% and 59%, respectively; P < 0.001) in group C than in groups A and B at 48 h postoperatively. There were no significant differences in the incidence of PONV or need for rescue antiemetics 0–2 h postoperatively, but significant differences were observed in the incidence of PONV and complete response among the three groups 2–48 h postoperatively. No statistically significant intergroup differences were observed in postoperative pain, PCA consumption, or adverse events. CONCLUSION: Intravenous administration of ramosetron at 0.3 mg reduced the incidence of PONV and rescue antiemetic requirement in craniotomy patients. Ramosetron at 0.3 mg was more effective than ondansetron at 4 or 8 mg for preventing PONV in adult craniotomy patients. TRIAL REGISTRATION: Clinical Research Information Service (CRiS) Identifier: KCT0000320. Registered 9 January 2012. BioMed Central 2014-08-04 /pmc/articles/PMC4124476/ /pubmed/25104916 http://dx.doi.org/10.1186/1471-2253-14-63 Text en Copyright © 2014 Ryu et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Ryu, Jung-Hee Lee, Ji-Eun Lim, Young-Jin Hong, Deok-Man Park, Hee-Pyoung Han, Jong-In Baik, Hee-Jung Kim, Hyun-Zu Min, Kyeong-Tae Do, Sang-Hwan A prospective, randomized, double-blind, and multicenter trial of prophylactic effects of ramosetronon postoperative nausea and vomiting (PONV) after craniotomy: comparison with ondansetron |
title | A prospective, randomized, double-blind, and multicenter trial of prophylactic effects of ramosetronon postoperative nausea and vomiting (PONV) after craniotomy: comparison with ondansetron |
title_full | A prospective, randomized, double-blind, and multicenter trial of prophylactic effects of ramosetronon postoperative nausea and vomiting (PONV) after craniotomy: comparison with ondansetron |
title_fullStr | A prospective, randomized, double-blind, and multicenter trial of prophylactic effects of ramosetronon postoperative nausea and vomiting (PONV) after craniotomy: comparison with ondansetron |
title_full_unstemmed | A prospective, randomized, double-blind, and multicenter trial of prophylactic effects of ramosetronon postoperative nausea and vomiting (PONV) after craniotomy: comparison with ondansetron |
title_short | A prospective, randomized, double-blind, and multicenter trial of prophylactic effects of ramosetronon postoperative nausea and vomiting (PONV) after craniotomy: comparison with ondansetron |
title_sort | prospective, randomized, double-blind, and multicenter trial of prophylactic effects of ramosetronon postoperative nausea and vomiting (ponv) after craniotomy: comparison with ondansetron |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124476/ https://www.ncbi.nlm.nih.gov/pubmed/25104916 http://dx.doi.org/10.1186/1471-2253-14-63 |
work_keys_str_mv | AT ryujunghee aprospectiverandomizeddoubleblindandmulticentertrialofprophylacticeffectsoframosetrononpostoperativenauseaandvomitingponvaftercraniotomycomparisonwithondansetron AT leejieun aprospectiverandomizeddoubleblindandmulticentertrialofprophylacticeffectsoframosetrononpostoperativenauseaandvomitingponvaftercraniotomycomparisonwithondansetron AT limyoungjin aprospectiverandomizeddoubleblindandmulticentertrialofprophylacticeffectsoframosetrononpostoperativenauseaandvomitingponvaftercraniotomycomparisonwithondansetron AT hongdeokman aprospectiverandomizeddoubleblindandmulticentertrialofprophylacticeffectsoframosetrononpostoperativenauseaandvomitingponvaftercraniotomycomparisonwithondansetron AT parkheepyoung aprospectiverandomizeddoubleblindandmulticentertrialofprophylacticeffectsoframosetrononpostoperativenauseaandvomitingponvaftercraniotomycomparisonwithondansetron AT hanjongin aprospectiverandomizeddoubleblindandmulticentertrialofprophylacticeffectsoframosetrononpostoperativenauseaandvomitingponvaftercraniotomycomparisonwithondansetron AT baikheejung aprospectiverandomizeddoubleblindandmulticentertrialofprophylacticeffectsoframosetrononpostoperativenauseaandvomitingponvaftercraniotomycomparisonwithondansetron AT kimhyunzu aprospectiverandomizeddoubleblindandmulticentertrialofprophylacticeffectsoframosetrononpostoperativenauseaandvomitingponvaftercraniotomycomparisonwithondansetron AT minkyeongtae aprospectiverandomizeddoubleblindandmulticentertrialofprophylacticeffectsoframosetrononpostoperativenauseaandvomitingponvaftercraniotomycomparisonwithondansetron AT dosanghwan aprospectiverandomizeddoubleblindandmulticentertrialofprophylacticeffectsoframosetrononpostoperativenauseaandvomitingponvaftercraniotomycomparisonwithondansetron AT ryujunghee prospectiverandomizeddoubleblindandmulticentertrialofprophylacticeffectsoframosetrononpostoperativenauseaandvomitingponvaftercraniotomycomparisonwithondansetron AT leejieun prospectiverandomizeddoubleblindandmulticentertrialofprophylacticeffectsoframosetrononpostoperativenauseaandvomitingponvaftercraniotomycomparisonwithondansetron AT limyoungjin prospectiverandomizeddoubleblindandmulticentertrialofprophylacticeffectsoframosetrononpostoperativenauseaandvomitingponvaftercraniotomycomparisonwithondansetron AT hongdeokman prospectiverandomizeddoubleblindandmulticentertrialofprophylacticeffectsoframosetrononpostoperativenauseaandvomitingponvaftercraniotomycomparisonwithondansetron AT parkheepyoung prospectiverandomizeddoubleblindandmulticentertrialofprophylacticeffectsoframosetrononpostoperativenauseaandvomitingponvaftercraniotomycomparisonwithondansetron AT hanjongin prospectiverandomizeddoubleblindandmulticentertrialofprophylacticeffectsoframosetrononpostoperativenauseaandvomitingponvaftercraniotomycomparisonwithondansetron AT baikheejung prospectiverandomizeddoubleblindandmulticentertrialofprophylacticeffectsoframosetrononpostoperativenauseaandvomitingponvaftercraniotomycomparisonwithondansetron AT kimhyunzu prospectiverandomizeddoubleblindandmulticentertrialofprophylacticeffectsoframosetrononpostoperativenauseaandvomitingponvaftercraniotomycomparisonwithondansetron AT minkyeongtae prospectiverandomizeddoubleblindandmulticentertrialofprophylacticeffectsoframosetrononpostoperativenauseaandvomitingponvaftercraniotomycomparisonwithondansetron AT dosanghwan prospectiverandomizeddoubleblindandmulticentertrialofprophylacticeffectsoframosetrononpostoperativenauseaandvomitingponvaftercraniotomycomparisonwithondansetron |